172 related articles for article (PubMed ID: 3163938)
1. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.
Egorin MJ; Snyder SW; Cohen AS; Zuhowski EG; Subramanyam B; Callery PS
Cancer Res; 1988 Apr; 48(7):1712-6. PubMed ID: 3162401
[TBL] [Abstract][Full Text] [Related]
3. Effects of the monoamine oxidase inhibitor, tranylcypromine, on induction of HL60 cell differentiation by hexamethylene bisacetamide and N-acetyl-1,6-diaminohexane.
Snyder SW; Egorin MJ; Zuhowski EG; Schimpff EC; Callery PS
Cancer Commun; 1990; 2(7):231-6. PubMed ID: 2378784
[TBL] [Abstract][Full Text] [Related]
4. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
5. Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites.
Egorin MJ; Zuhowski EG; Cohen AS; Geelhaar LA; Callery PS; Van Echo DA
Cancer Res; 1987 Nov; 47(22):6142-6. PubMed ID: 3664514
[TBL] [Abstract][Full Text] [Related]
6. An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.
Subramanyam B; Callery PS; Egorin MJ; Snyder SW; Conley BA
Drug Metab Dispos; 1989; 17(4):398-401. PubMed ID: 2571479
[TBL] [Abstract][Full Text] [Related]
7. [Immobilization of N-acetyl-1,6-diaminohexane(NADAH) on diol-silica and study of mechanism of NADAH and hexamethylene bisacetamide(HMBA) inducing tumor cells differentiation].
Xie D; Ren L; Li LS
Se Pu; 1998 Jul; 16(4):327-30. PubMed ID: 11367764
[TBL] [Abstract][Full Text] [Related]
8. Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA).
Conley BA; Callery PS; Egorin MJ; Subramanyam B; Geelhaar LA; Pan SS
Life Sci; 1988; 43(9):793-800. PubMed ID: 3137409
[TBL] [Abstract][Full Text] [Related]
9. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor.
Imaizumi M; Uozumi J; Breitman TR
Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.
Callery PS; Egorin MJ; Geelhaar LA; Nayar MS
Cancer Res; 1986 Oct; 46(10):4900-3. PubMed ID: 3756851
[TBL] [Abstract][Full Text] [Related]
14. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Hassan HT; Rees JK
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
[TBL] [Abstract][Full Text] [Related]
15. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
16. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
17. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
Yamashita T; Eto Y; Shibai H; Ogata E
Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic chromatography of the HL-60 cellular fraction co-binding with hexamethylene bisacetamide.
Xie D; Li S; Ren L
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):359-63. PubMed ID: 9061477
[TBL] [Abstract][Full Text] [Related]
19. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on hexamethylene bisacetamide-induced Friend cell erythrodifferentiation.
Osborne HB; Bakke AC; Yu J
Cancer Res; 1982 Feb; 42(2):513-8. PubMed ID: 6173113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
